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Introduction: Endotoxemia and the systemic inflammatory response syndrome have a significant impact on
post-surgery outcome, particularly in the elderly. The cytokine response to endotoxin is altered by aging. We tested the
hypothesis that vulnerability to endotoxemic cardiac depression increases with aging due to age-related augmentation
of myocardial inflammatory responses.
Methods: Adult (4 to 6 months) and old (20 to 22 months) C57/BL6 mice were treated with endotoxin (0.5 mg/kg, iv).
Left ventricle (LV) function was assessed using a microcatheter system. Chemokines and cytokines in plasma and
myocardium were analyzed by enzyme-linked immunosorbent assay (ELISA). Mononuclear cells in the myocardium
were examined using immunofluorescence staining.
Results: Old mice displayed worse LV function (cardiac output: 3.0 ± 0.2 mL/min versus 4.4 ± 0.3 mL/min in adult mice)
following endotoxin treatment. The exaggerated cardiac depression in old mice was associated with higher levels of
monocyte chemoattractant protein-1 (MCP-1) and keratinocyte chemoattractant (KC) in plasma and myocardium,
greater myocardial accumulation of mononuclear cells, and greater levels of tumor necrosis factor-α (TNF-α), interleukin
1β (IL-1β) and interleukin 6 (IL-6) in plasma and myocardium. Neutralization of MCP-1 resulted in greater reductions in
myocardial mononuclear cell accumulation and cytokine production, and greater improvement in LV function in old
mice while neutralization of KC had a minimal effect on LV function.
Conclusion: Old mice have enhanced inflammatory responses to endotoxemia that lead to exaggerated cardiac
functional depression. MCP-1 promotes myocardial mononuclear cell accumulation and cardiodepressant cytokines
production, and plays an important role in the endotoxemic cardiomyopathy in old mice. The findings suggest that
special attention is needed to protect the heart in the elderly with endotoxemia.Introduction
It is well known that cardiac contractile dysfunction
caused by bacterial endotoxin is associated with the pro-
duction of pro-inflammatory mediators [1]. Toll-like re-
ceptor 4 (TLR4) plays a central role in the regulation of
endotoxin signaling and endotoxin-induced production
of multiple pro-inflammatory mediators [2]. We and
others have observed that endotoxin induces cardiac
contractile depression through upregulation of myocar-
dial production of pro-inflammatory cytokines, such as
TNF-α and IL-1β [3-6].* Correspondence: xianzhong.meng@ucdenver.edu
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unless otherwise stated.Trauma and stress associated with major surgery can
cause gut bacteria translocation, which leads to endotox-
emia and the systemic inflammatory response [7,8]. The
number of major surgery performed on the elderly is
increasing with the increase in life expectancy. The
systemic inflammatory response associated with major
surgery has a significant impact on the post-surgery out-
come in the geriatric population [9,10]. It has been re-
ported that elderly patients with systemic inflammatory
response syndrome have higher incidence of morbidity
and mortality than younger patients [11]. Although inci-
dence of systemic inflammatory response syndrome and
associated mortality in humans is increasing with age,
the mechanism of age-associated vulnerability to this syn-
drome remains unclear. Understanding of the mechanismLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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heart is important for peri-surgical care in the elderly.
Endotoxemia depresses cardiac function via upregulation
of the expression of cardiodepressant cytokines, including
TNF-α, IL-1β and IL-6 [4,5,12]. IL-6 expression is elevated
in several tissues of old mice [13]. In addition, aging has
been shown to exacerbate the cytokine response to pro-
inflammatory insults, including endotoxin, trauma, and
ischemia/reperfusion injury [14-18]. Thus, it is likely that
aging upregulates the myocardial inflammatory responses to
endotoxin and exaggerates endotoxemic cardiac depression.
Mononuclear cells are major sources of tissue pro-
inflammatory cytokines [19]. While endotoxin induces
mononuclear cell infiltration to the myocardium and
other tissues [20], the effect of aging on mononuclear
cell accumulation in the myocardium during endotox-
emia is unclear. Further, the impacts of myocardial
mononuclear cell accumulation and associated cyto-
kine production on cardiac functional performance in
the aging heart remain to be determined.
We tested the hypothesis that vulnerability to endo-
toxemic cardiac depression increases with aging due to
age-related augmentation of the systemic and myocardial
inflammatory responses. The purposes of this study are:
1) to examine whether aging mice have exaggerated car-
diac contractile depression when exposed to endotoxin,
2) to determine whether endotoxemic cardiac depres-
sion, as a function of age, correlates with the levels
of systemic and myocardial inflammatory responses and
3) to identify the factor that is responsible for the cyto-
kine response and cardiac depression in aging mice.
Materials and methods
Animals and treatment
Adult (4 to 6 months) and old (20 to 22 months) male
C57BL/6 mice were obtained from the Jackson Laboratory
(Bar Harbor, Maine, USA) and National Institute on Aging
(Bethesda, MD, USA). Mice were acclimated for 14 days
in a 12:12-h light-dark cycle with free access to water and
regular chow diet before the experiments. The experiments
were approved by the Institutional Animal Care and Use
Committee of the University of Colorado Denver, and
this investigation conforms to the Guide for the Care
and Use of Laboratory Animals (National Research Coun-
cil, revised 1996).
Adult and old animals were assigned to one of the
following experimental groups (n = 6 in each group): nor-
mal saline group, lipopolysaccharide (LPS) group, LPS +
monocyte chemoattractant protein-1 (MCP-1)-neutraliz-
ing antibody group and LPS + keratinocyte chemoattract-
ant (KC)-neutralizing antibody group. All treatments were
performed in the morning. LPS (Escherichia coli 0111:B4,
Sigma Chemical Co, Saint Louis, MO, USA) in a dose of
0.5 mg/kg was injected through a tail vein. Controlanimals were treated with the same volume of sterile nor-
mal saline. Neutralizing antibody against MCP-1 or KC
(R&D Systems, Minneapolis, MN, USA) was injected
through a tail vein 1 h after injection of LPS. The animals
were observed for 6 h after injection of LPS or saline.
After analysis of cardiac function, the heart tissue and
blood were collected and prepared for analysis of chemo-
kines and cytokines.
Measurement of cardiac function
We assessed cardiac function at 6 h after LPS treatment as
described previously [21,22]. Briefly, mice were anesthe-
tized with pentobarbital sodium (Vortech Pharmaceuticals,
Dearborn, MI, USA; 50 mg/kg, intraperitoneal (ip)) and
anticoagulated with heparin (Elkins-Sinn, Cherry Hill,
NJ, USA; 1,000 units/kg, ip). Animals were laid su-
pine on a heating blanket and core body temperature
was maintained at 37°C ± 0.5°C. A microcatheter (Millar
Instruments, Houston, TX, USA; 1 F) was inserted into
the left ventricle (LV) through the right common carotid
artery. Pressure-volume loop was recorded using the
MPVS-400 system with the aid of PVAN software (Millar
Instruments). Heart rates, LV pressure, LV volume, and
related function parameters were analyzed: 10 μL of 30%
saline was injected into the inferior vena cava for actual
ventricle volume calculation.
Immunofluorescence staining
The optimal cutting temperature (OCT)-embedded tis-
sues were cut into thin sections (5-μm thick). Sections
were treated with a mixture of 30% acetone and 70%
methanol for 5 minutes, washed with PBS and fixed with
4% paraformaldehyde. Then sections were incubated
with a rabbit polyclonal antibody against murine CD68
(a marker of mononuclear cells, including monocytes
and macrophages) followed by Cy3-tagged goat anti-rabbit
IgG (imaged on the red channel). Nuclei were stained with
bis-benzimide (4′,6-diamidino-2-phenylindole (DAPI), im-
aged on the blue channel), and glycoproteins on cell sur-
faces were stained with Alexa 488-tagged wheat germ
agglutinin (imaged on the green channel). Microscopy was
performed with a Leica DMRXA digital microscope (Leica
Mikroskopie and System GmbH, Wetzlar, Germany).
Images were analyzed in a blinded fashion.
ELISA
Commercial ELISA kits (R & D Systems) were utilized
to quantify chemokines (MCP-1, KC and macrophage
inflammatory protein-1α (MIP-1α)) and cytokines (TNF-α,
IL-1β and IL-6) in plasma and myocardial tissue homoge-
nates, as well as cardiac troponin-I (cTn-I) in plasma.
Samples and standards were prepared according to
manufacturer's instructions. Absorbance of standards
and samples were determined spectrophotometrically at
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Inc, Hercules, CA, USA). Results were plotted against the
linear portion of a standard curve.
Statistical analysis
Data are presented as mean ± standard error (SE). Statis-
tical analysis was performed using StatView software
(Abacus Concepts, Calabasas, CA, USA). Analysis of
variance (ANOVA) with Fisher post-hoc test was used to
analyze differences between experimental groups, and
differences were confirmed using the Mann-Whitney
U-test. Statistical significance was defined as P ≤0.05.
Results
Endotoxemia results in worse cardiac depression in
old mice
We determined whether endotoxemia causes greater
cardiac depression in old mice than in adult mice. Heart
rate increased in both adult and old mice treated with
endotoxin in comparison to saline-treated controls
(Table 1). Compared to the control group, ejection frac-
tion and developed pressure decreased in endotoxin-
treated adults and old mice. Similarly, cardiac output
was decreased in both adult and old mice after endo-
toxin treatment. The representative pressure-volume
loops in Figure 1A and analyzed data in Table 1
show significantly greater decreases in LV function in
old mice. Thus, endotoxemia causes a reduction in LV
function, and old mice have worse LV function during
endotoxemia.
To examine whether exaggerated cardiac depression in
old mice is associated with worse myocardial injury,
we analyzed cardiac Tn-I levels in the plasma, as it is a
reliable marker of myocardial injury [23]. As shown in
Figure 1B, treatment with LPS caused a significant in-
crease in plasma levels of cardiac Tn-I in both adult and
old mice, although the concentrations were not very
high. The release of cardiac Tn-I was greater in old miceTable 1 Left ventricle function parameters
Parameter Control LPS
Adult Old Adult O
Heart rate (bpm) 430 ± 13 427 ± 15 490 ± 25* 5
Developed pressure (mmHg) 83.0 ± 5.0 79.0 ± 3.5 57.0 ± 2.0* 4
End-systolic volume (μL) 7.0 ± 2.3 8.1 ± 2.5 18.0 ± 2.0* 2
End-diastolic volume (μL) 21.0 ± 1.5 20.1 ± 1.7 27.0 ± 1.8* 3
Ejection fraction (%) 66.1 ± 4.2 60.0 ± 4.8 33.1 ± 2.8* 2
Cardiac output (mL/min) 5.9 ± 0.4 5.2 ± 0.4 4.4 ± 0.3* 3
Mice were treated with lipopolysaccharide (LPS, 0.5 mg/kg) for 6 h. Both adult and
displayed worse LV performance, including developed pressure, ejection fraction an
chemoattractant protein-1(MCP-1)-neutralizing antibody (NAb) improved LV functio
contrast, neutralization of keratinocyte chemoattractant (KC) had a minimal effect
corresponding control; †P <0.05 versus adult mice with the same treatment; #P <0(626 ± 40 pg/mL in old mice versus 410 ± 25 pg/mL in
adult mice; P <0.05, n = 6). Therefore, the exaggerated
LV dysfunction in old mice is associated with augmented
myocardial injury.
Aging augments MCP-1 and KC production during
endotoxemia
Treatment with endotoxin increased the levels of MCP-1
and KC in plasma and the myocardium (Figure 2A and B).
Interestingly, old mice had significantly higher levels of
MCP-1 and KC in plasma and the myocardium than adult
mice. While MIP-1α levels also increased after endotoxin
treatment, there was no significant difference in MIP-1α
levels between adult and old mice (data not shown).
Old mice display greater myocardial mononuclear cell
accumulation and cytokine production
We analyzed mononuclear cell accumulation in myocar-
dial tissue, as well as the levels of pro-inflammatory cyto-
kines (TNF-α, IL-1β and IL-6) in plasma and myocardial
tissue of adult and old mice. The number of mononuclear
cells increased following endotoxin treatment (Figure 3A).
Old mice, however, exhibited greater mononuclear cell
accumulation in the myocardium (Figure 3A).
As shown in Figure 3B, levels of TNF-α, IL-1β and IL-6
increased in myocardial tissue after endotoxin treatment
in adult and old mice. Old mice, however, displayed higher
levels of myocardial TNF-α (110 ± 10 pg/mL in the old
versus 66 ± 5 pg/mL in adults; P <0.05, n = 6), IL-1β
(310 ± 25 pg/mL in the old versus 190 ± 13 pg/mL in
adult; P <0.05, n = 6) and IL-6 (667 ± 51 ng/mL in the
old versus 322 ± 17 ng/mL in adult; P <0.05, n = 6) com-
pared to adult mice. Similar differences between adult
and old mice were observed in plasma levels of these cy-
tokines (Figure 3C). Thus, augmented myocardial pro-
duction of cardiodepressant cytokines in aging mice is
associated with enhanced mononuclear cell accumulation
in the myocardium.LPS + KC NAb LPS +MCP-1 NAb
ld Adult Old Adult Old
30 ± 23* 481 ± 18* 508 ± 20* 492 ± 30* 501 ± 20*
6.0 ± 1.9*† 62.0 ± 4.5* 51.1 ± 5.0*† 73.1 ± 4.0*# 68.2 ± 2.7*#
4.5 ± 2.2*† 18.2 ± 1.5* 23.5 ± 1.1*† 11.0 ± 1.0*# 15.0 ± 1.5*†#
0.1 ± 2.8* 28.0 ± 1.5* 30.1 ± 3.1* 22.0 ± 1.1# 24.0 ± 1.8#
0.0 ± 1.8*† 37.1 ± 2.5* 22.1 ± 1.8*† 49.1 ± 3.7*# 39.0 ± 2.6*†#
.0 ± 0.2*† 4.8 ± 0.3* 3.3 ± 0.3*† 5.4 ± 0.3# 4.5 ± 0.4#
old mice displayed significantly reduced left ventricle (LV) function. Old mice
d cardiac output, compared with adult mice. Treatment with monocyte
n in both adult and old mice, and old mice had a greater improvement. In
on LV function. Data are expressed as mean ± standard error. *P <0.05 versus
.05 versus LPS alone.
AAdult control Adult LPS


























Figure 1 Endotoxemia results in greater cardiac depression and worse myocardial injury in old mice. Adult and old mice were treated
with lipopolysaccharide (LPS, 0.5 mg/kg, iv) or normal saline. Left ventricular pressure-volume loops and plasma levels cardiac troponin-I (cTn-I)
were analyzed 6 h after treatment. Old mice displayed greater reduction in left ventricular performance (A) and higher levels of cTn-I in plasma
(B). Data are expressed as mean ± standard error; *P <0.05 versus corresponding control (Ctrl); #P <0.05 versus adult mice with LPS treatment.
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myocardial mononuclear cell accumulation and cytokine
production
We applied specific neutralizing antibodies to determine
the role of MCP-1 and KC in myocardial mono-
nuclear cell accumulation and cytokine production in
adult and old mice. In comparison to mice treated with
endotoxin alone, mice treated with endotoxin plus MCP-
1-neutralizing antibody had markedly lower densities of
mononuclear cells in the myocardium (Figure 4A). While
the reduction in mononuclear cell accumulation was ob-
served in both adult and old mice, a greater reductionwas attained in old mice, resulting in the abrogation of
an age-related difference. In contrast, neutralization of
KC had a minimal effect on myocardial mononuclear cell
accumulation in either adult or old mice (Figure 4A).
Myocardial cytokines (TNF-α, IL-1β and IL-6) levels
were also markedly reduced in mice treated with endo-
toxin plus MCP-1-neutralizing antibody in comparison
to mice treated with endotoxin alone (Figure 4B). How-
ever, neutralizing KC had a minimal effect on myocardial
production of these cytokines although plasma levels
of TNF-α and IL-1β are moderately reduced by KC-















































































Figure 2 Old mice have higher levels of chemokines in the myocardium and plasma. Adult and old mice were treated with lipopolysaccharide
(LPS, 0.5 mg/kg, iv) or normal saline. Levels of MCP-1 and KC were analyzed by ELISA 6 h after treatment. Old mice had higher levels of MCP-1 and KC
in myocardial tissue (A) and plasma (B). Data are expressed as mean ± standard error. *P <0.05 versus corresponding control (Ctrl); #P <0.05 versus adult
mice treated with LPS.
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the age-related differences in myocardial cytokine levels
are essentially abolished (Figure 4B). Similar results
for plasma cytokine levels were obtained (Figure 4C).
Thus, neutralization of MCP-1 reduced mononuclear
cell accumulation in the myocardium and suppressed
cardiodepressant cytokine production during endo-
toxemia, particularly in old mice.
Neutralization of MCP-1 reduces myocardial injury and
improves LV function in old endotoxemic mice
We determined the effect of neutralization of MCP-1 or
KC on LV function and myocardial injury in adult and
old mice. We found that LV performance was improved
by administration of MCP-1-neutralizing antibody in
both adult and old mice (Table 1). In comparison to
mice treated with endotoxin alone, developed pressure
increased by 48% in old mice treated with endotoxin
plus MCP-1-neutralizing antibody, and it increased by
28% in adult mice receiving the same treatment. Ejection
fraction in old mice treated with endotoxin plus MCP-1-
neutralizing antibody increased by 95% while it increased
by 48% in adult mice receiving the same treatment. Simi-
larly, cardiac output increased by 50% and 23% in old
mice and adult mice, respectively, by treatment withMCP-1-neutralizing antibody. However, KC-neutralizing
antibody had a minimal effect on LV function parameters
in either adult or old endotoxemic mice. As shown in
Figure 5, neutralization of MCP-1 also reduced plasma
levels of cardiac Tn-I in both adult and old mice, with a
bigger reduction in the latter. Noticeably, a minimal re-
duction in plasma levels of cardiac Tn-I was achieved by
neutralization of KC in either adult or old mice.
Discussion
In the present study, we observed that old mice ex-
hibit worse LV function during endotoxemia. Exagger-
ated cardiac depression in old mice is associated with
higher levels of MCP-1 and KC in plasma and myo-
cardium, greater myocardial accumulation of mono-
nuclear cells (monocytes and macrophages), augmented
production of TNF-α, IL-1β and IL-6 in the myocardium,
and worse myocardial injury. Neutralization of MCP-1
results in greater reductions in mononuclear cell accu-
mulation and cytokine production in the myocardium,
attenuates myocardial injury and markedly improves
LV function, particularly in old mice. Thus, MCP-1
plays an important role in myocardial inflammatory re-






















































































































































Adult Ctrl  Old Ctrl  Adult LPS  Old LPS Adult Ctrl  Old Ctrl  Adult LPS  Old LPS Adult Ctrl  Old Ctrl  Adult LPS  Old LPS
Adult Ctrl  Old Ctrl  Adult LPS  Old LPS Adult Ctrl  Old Ctrl  Adult LPS  Old LPSAdult Ctrl  Old Ctrl  Adult LPS  Old LPS
Figure 3 Myocardial mononuclear cell accumulation and pro-inflammatory cytokine production are enhanced in old mice. Adult and
old mice were treated with lipopolysaccharide (LPS, 0.5 mg/kg, iv) or normal saline. Mononuclear cells in the myocardium were detected by
immunofluorescence staining using a polyclonal antibody against murine CD68 (red), and levels of TNF-α, IL-1β, and IL-6 in the myocardium and
plasma were measured by ELISA 6 h after LPS treatment. The myocardium of old mice displayed higher densities of mononuclear cells (arrow)
after LPS treatment (A) (size bar = 20 μm). In addition, the levels of TNF-α, IL-1β, and IL-6 were higher in the myocardium (B) and plasma (C) of
old mice compared to adult mice. Data are expressed as mean ± standard error. *P <0.05 versus corresponding control (Ctrl); #P <0.05 versus adult
mice treated with LPS.
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mice are associated with augmented cytokine production
Elderly patients with sepsis or septic shock have a higher
mortality rate [24]. During sepsis, the inflammatory re-
sponses mediate cardiovascular abnormalities, including
vascular endothelial cell damage, increased vascular per-
meability, hypotension and cardiac contractile dysfunc-
tion [25]. To understand whether there is an age-related
difference in the vulnerability to endotoxemic cardiac
depression, the present study compared LV function
in adult and old mice following endotoxin treatment.
We observed that LV function is compromised after ad-
ministration of endotoxin in both adult and old mice.However, old mice display worse LV function in com-
parison to adult mice when being challenged with the
same dose of endotoxin. It is evident that developed
pressure and ejection fraction are lower in old endotoxe-
mic mice. Similarly, old endotoxemic mice have lower
cardiac output. These results demonstrate that old mice
are more vulnerable to endotoxemic cardiac depression,
displaying greater reductions in LV contractility and
overall cardiac performance. In addition, the greater in-
crease in circulating levels of cardiac Tn-I in old mice
indicates greater myocardial injury.
A number of studies have demonstrated that cardiac






























































































































































































Figure 4 Neutralization of monocyte chemoattractant protein-1 (MCP-1) reduces myocardial mononuclear cell accumulation and
cytokine production in old mice. MCP-1-neutralizing antibody or keratinocyte chemoattractant (KC)-neutralizing antibody (NAb or ab;
8 μg/mouse, iv) were administered 60 minutes after injection of lipopolysaccharide (LPS, 0.5 mg/kg, iv). Mononuclear cells in the myocardium were
detected by immunofluorescence staining, and levels of TNF-α, IL-1β, and IL-6 in the myocardium and plasma were analyzed by ELISA 6 h after LPS
treatment. Neutralization of MCP-1, not KC, reduced myocardial mononuclear cell density (A) and cytokine levels in the myocardium and
plasma (B and C). Greater reductions were observed in old mice. Data are expressed as mean ± standard error. *P <0.05 versus corresponding
control (Ctrl); #P <0.05 versus adult mice treated with LPS alone or LPS + KC-NAb; †P <0.05 versus corresponding age group treated with LPS
alone or LPS + KC-Nab.
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In addition, pro-inflammatory cytokines have been im-
plicated in cardiac dysfunction after acute injuries
caused by burns [26], sepsis [27], and myocardial ische-
mia and reperfusion [28]. Intravenous administration of
either TNF-α or IL-1β can induce a similar change to
that caused by endotoxemia and endotoxic shock [29,30],
and cardiovascular abnormalities, and mortality can be
ameliorated by applying IL-1β receptor antagonist or
anti-TNF-α antibodies [31,32]. Previous studies by our
group and others demonstrated that intercellular adhe-
sion molecule-1 (ICAM-1) also plays an important role
in the endotoxemic cardiac dysfunction and that TNF-α
links TLR4 activation to myocardial ICAM-1 expression
[6,33]. In the present study, we observed that endotoxin
increases the levels of TNF-α, IL-1β and IL-6 in plasma
and myocardial tissue of adult and old mice, and the
cytokine response is augmented in old mice. While
higher levels of TNF-α, IL-1β and IL-6 in plasma and tis-
sues of old endotoxemic animals have been reported[14,16-18], few studies have determined the relationship
between the augmented cytokine response and cardiac
performance in old animals. The results of the present
study show that the worse cardiac performance in old
mice is associated with higher levels of TNF-α, IL-1β and
IL-6 in plasma and myocardial tissue. Our results suggest
that significantly higher levels of cardiodepressant cyto-
kines in the myocardium contribute, at least partly,
to the mechanism of exaggerated cardiac depression in
old mice.
Previous studies suggest that inducible nitric oxide
synthase (iNOS) and nitric oxide (NO) mediate the effect
of myocardial depressant cytokines, including TNF-α,
IL-1β and IL-6 [3,5,34]. Indeed, NO and peroxynitrite
inhibit myocardial O2 consumption [35], and reduce
the heart’s ability to utilize ATP for contractile work [36].
However, our previous study demonstrates that pro-
inflammatory cytokines contribute cardiac depression in
this endotoxemia model through an NO-independent





























Figure 5 Neutralization of monocyte chemoattractant protein-1
(MCP-1) reduces myocardial injury. MCP-1-neutralizing antibody
or keratinocyte chemoattractant (KC)-neutralizing antibody (NAb;
8 μg/mouse, iv) were administered 60 minutes after injection of
lipopolysaccharide (LPS, 0.5 mg/kg, iv). Plasma levels of cardiac
troponin-I (cTn-I) were analyzed by ELISA 6 h after LPS treatment.
Neutralization of MCP-1, not KC, reduced cTn-I levels in plasma.
Old mice displayed a greater reduction although cTn-I levels
remain higher than those of adult mice receiving the same treatment.
Data are expressed as mean ± standard error. *P <0.05 versus
corresponding age group treated with LPS alone; #P <0.05 versus
adult mice receiving the same treatment.
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jury. In this regard, we have observed that perfusion of
TNF-α to isolated hearts results in myocardial injury and
contractile depression [28]. In addition, endotoxin and
cytokines have been shown to directly depress the con-
tractility in cultured cardiomyocytes [12,38]. It is note-
worthy that myocardial injury could contribute to cardiac
functional deficit caused by endotoxin although the levels
of circulating cardiac Tn-I is rather low, even in old mice
exposed to endotoxin.
Enhanced MCP-1 production plays an important role in
upregulating cytokine response and mediating LV
dysfunction in old mice
Augmented production of chemokines, that is, KC and
MCP-1, in response to endotoxin is observed in both
plasma and myocardial tissue of old mice. It is possible
that the greater levels of pro-inflammatory cytokines in
the myocardium of old mice are due to chemokine-
mediated leukocyte accumulation in the myocardium.
Neutrophil infiltration occurs in the myocardium during
endotoxemia or endotoxic shock [39,40], and IL-8 is an
important chemoattractant factor for neutrophils [41].
In the present study, we observed a significant increase
in circulating and myocardial levels of KC, a murine
analog of human IL-8, in mice treated with endotoxin.
However, we previously observed moderate myocardial
neutrophil infiltration in this model of endotoxemiainduced by a low dose of endotoxin, and depletion of
neutrophils with a monoclonal antibody has no effect
on cardiac dysfunction in this model [33]. Furthermore,
neutralization of KC has no significant effect on LV func-
tion. Thus, myocardial neutrophils have not been the
central theme of this study.
Infiltrated mononuclear cells are important sources of
tissue pro-inflammatory cytokines [42]. MCP-1 is a
member of the C-C chemokine family, and a potent
chemotactic factor for monocytes [43]. MCP-1 is
produced by many cell types and regulates the migra-
tion and infiltration of monocytes and lymphocytes.
Neutralization of MCP-1 has been shown to reduce
leukocyte recruitment and prevent tissue injury in a rat
model of endotoxin-induced intestinal muscularis and
gastrointestinal dysmotility [44]. In the present study, we
observed that MCP-1 levels in plasma and myocardial
tissue are significantly higher in the old mice than adult
mice after administration of endotoxin, which is accom-
panied by higher levels of mononuclear cell accumulation
in the myocardium and greater production of pro-
inflammatory cytokines. MCP-1-neutralizing antibody
reduces mononuclear cell accumulation, as well as pro-
inflammatory cytokine production, in the myocardium of
old mice. In contrast, neutralization of KC has a minimal
effect on myocardial mononuclear cell accumulation and
cytokine production although it reduces plasma levels of
TNF-α and IL-1β. The results of the present study sup-
port the notion that MCP-1 plays an important role in
the overall myocardial inflammatory responses, and en-
hanced MCP-1 production is responsible for greater
myocardial mononuclear cell accumulation and cytokine
production in old mice. However, it should be noted that
myocardia cytokines can come from multiple additional
sources, including resident macrophages, microvascular
endothelial cells, fibroblasts and cardiomyocytes. The ef-
fects of MCP-1-neutralizing antibody on mononuclear
cell accumulation and myocardial cytokine production
only show an association of these two inflammatory
events. It remains unclear from this study whether infil-
trated mononuclear cells are the main source of myocar-
dial cytokines and whether MCP-1 has any direct or
indirect effect on other cells in the heart that are capable
of producing cytokines. These questions need to be an-
swered by future studies.
Importantly, we observed that treatment with MCP-1-
neutralizing antibody results in a greater improvement
in LV function in old mice than in adult mice. For ex-
ample, ejection fraction was improved by 48% in adult
mice, but it was improved by 95% in old mice. While
the age-related differences remained in some LV func-
tional parameters, such as ejection fraction, the differ-
ences became much smaller following treatment with
MCP-1-neutralizing antibody. Thus, neutralization of
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in both adult and old mice and reduced the difference
in LV functional deficit between adult and old mice. It
should be noted that neutralization of KC had a min-
imal effect on LV function in either adult or old mice
although it moderately reduced plasma levels of TNF-α
and IL-1β. This finding indicates the importance of myo-
cardial cytokines, rather than circulating cytokines, in LV
dysfunction. The beneficial effect of MCP-1 neutralization
on cardiac function appears to be through reducing
myocardial production of cardiodepressant cytokines
and myocardial injury since markedly improved LV
function in old mice treated with MCP-1-neutralizing
antibody correlates to greater reductions in myocardial
levels of TNF-α, IL-1β and IL-6, and in plasma levels of
cardiac Tn-I. While both reduced myocardial inflamma-
tory responses and attenuated myocardial injury appear
to account for the marked improvement in LV function
in old mice, the myocardial injury may have a minor role
in cardiac dysfunction in this endotoxemia model. No-
ticeably, circulating levels of cardiac Tn-I remain higher
in old animals when the age-related difference in cardiac
output is abrogated.
Conclusions
Augmented myocardial cytokine production in response
to endotoxin results in worse cardiac depression in old
mice. Endotoxin induces greater MCP-1 production in
old mice, and this chemoattractant protein plays an im-
portant role in the augmentation of myocardial mono-
nuclear cell accumulation and cardiodepressant cytokine
production in old mice, leading to exaggerated myocar-
dial injury and worse LV functional performance. Thus,
MCP-1 appears to be a potential therapeutic target for
suppression of myocardial inflammatory responses and
for protection of cardiac function in the elderly with
endotoxemia.
Limitations
The endotoximia model has limitations. Although endo-
toxin is involved in several clinical conditions, such
as sepsis and systemic inflammatory response syn-
drome, it is only one of the multiple factors that me-
diate tissue inflammatory responses and injury seen
in the clinical settings. Investigation of the effect of a
single factor, that is, endotoxin, can improve the un-
derstanding of the mechanism by which this factor
exerts its effect. However, observations made in a
simplified model could not be extrapolated to the
complicated situation of sepsis and systemic inflam-
matory response syndrome. In addition, cardiac function
was analyzed under anesthesia. The effect of anesthetics
may introduce certain variability to the cardiac functional
parameters.Key messages
1. Old mice display exaggerated cardiac functional
depression during endotoxemia that is accompanied
by enhanced myocardial inflammatory responses.
2. MCP-1 promotes myocardial mononuclear cell
accumulation and cardiodepressant cytokine
production, and plays an important role in the
endotoxemic cardiomyopathy in old mice.
3. Special attention may be needed to protect the heart
in the elderly with endotoxemia.
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